dexmedetomidine has been researched along with resveratrol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
| Liu, T; Wang, X; Yao, Y; Zhang, D | 1 |
| Jiang, K; Jiang, L; Lei, L; Li, H; Li, J | 1 |
3 other study(ies) available for dexmedetomidine and resveratrol
| Article | Year |
|---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
The Contrary Effects of Sirt1 on MCF7 Cells Depend on CD36 Expression Level.
Topics: Adrenergic alpha-2 Receptor Agonists; Breast; Breast Neoplasms; CD36 Antigens; Cell Proliferation; Dexmedetomidine; Disease Progression; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Resveratrol; Signal Transduction; Sirtuin 1; Up-Regulation | 2019 |
PINK1-mediated mitophagy reduced inflammatory responses to Porphyromonas gingivalis in macrophages.
Topics: Dexmedetomidine; Humans; Interleukin-6; Macrophages; Mitophagy; Periodontitis; Porphyromonas gingivalis; Protein Kinases; Resveratrol; Tumor Necrosis Factor-alpha | 2023 |